Integrated Advisors Network’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Integrated Advisors Network's BIIB Position: Q3 2026 in Review
Integrated Advisors Network increased its Biogen (BIIB) stake by 3.5% in Q3 2026, buying an estimated $10.2K and bringing the position to 1,403 shares worth $317K. The position accounts for 0.01% of the portfolio, ranked #542.
Integrated Advisors Network first reported a position in BIIB in Q4 2019 and has held it in 21 quarters since. The position peaked at $580K in Q2 2024. 643 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Integrated Advisors Network held 1,403 shares of Biogen worth $317K as of Q3 2026.
- Integrated Advisors Network bought 48 Biogen shares in Q3 2026, an estimated $10.2K.
- Biogen made up 0.01% of Integrated Advisors Network's portfolio in Q3 2026, its #542 holding.
- Integrated Advisors Network first reported a position in Biogen in Q4 2019 and has held it in 21 quarters since.
- Integrated Advisors Network's Biogen position peaked at $580K in Q2 2024.
- 643 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Integrated Advisors Network's 13F filing for Q3 2026, filed 20 Oct 2026.